34
Participants
Start Date
June 30, 2014
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
BVM-UF biofeedback
The Fresenius 5008 uses an ultrasound and temperature monitor incorporated into the machine to detect ultrasonic velocity and temperature changes to derive the total protein concentration, which is a sum of total plasma proteins and hemoglobin. The relative blood volume is calculated at by dividing the initial concentration of total protein by the total protein concentration at any given time, multiplied by 100. The HD software is based on the critical blood volume entered at the beginning of the dialysis session for each individual patient. The UF rate is adjusted based on the changes in the relative blood volume to the patient's critical relative blood volume.
Fresenius 5008 HD machine (Fresenius Medical Care, Bad Homburg, Germany)
For an 8-week period, patients in the best clinical practice (control) phase will use their same prescription as the run-in phase, dialysate sodium of 138mmol/L, dialysate calcium of 1.25mmol/L, dialysate temperature of 36oC, and constant UF rate. BVM will be disabled in this group.
Alberta Health Services Southern Alberta Renal Program, Calgary
University of Calgary
OTHER